financetom
Business
financetom
/
Business
/
Abercrombie & Fitch lifts fourth-quarter sales target on strong holiday demand
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Abercrombie & Fitch lifts fourth-quarter sales target on strong holiday demand
Jan 13, 2025 4:28 AM

(Reuters) - Abercrombie & Fitch ( ANF ) on Monday raised its annual net sales growth target for the current quarter helped by strong demand for its apparel collections during the holiday shopping season.

The company now expects fourth-quarter net sales to grow between 7% and 8%, compared with the prior target of 5% to 7% growth.

(Reporting by Juveria Tabassum in Bengaluru; Editing by Mrigank Dhaniwala)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BioNTech guides for worse-than-expected 2025 revenue decline
BioNTech guides for worse-than-expected 2025 revenue decline
Mar 10, 2025
FRANKFURT, March 10 (Reuters) - German COVID-19 vaccine maker BioNTech on Monday said that its 2025 revenues would likely fall to between 1.7 billion euros ($1.85 billion) and 2.2 billion euros, prompting a decline in its share price. The guidance compares with revenues of 2.75 billion euros reported for last year and with an average analyst estimate of about 2.5...
Veren, Whitecap Agree on $10.4 Billion Business Combination in All-Share Transaction
Veren, Whitecap Agree on $10.4 Billion Business Combination in All-Share Transaction
Mar 10, 2025
07:31 AM EDT, 03/10/2025 (MT Newswires) -- Veren ( VRN ) said Monday it has entered into a definitive business combination agreement with Whitecap Resources to create a light oil and condensate producer with concentrated assets in the Alberta Montney and Duvernay. The all-share transaction is valued at approximately $10.4 billion, inclusive of net debt. Under the terms of the...
Trevi Therapeutics Says Phase 2a Haduvio Trial Shows Significant Reduction in Cough Count
Trevi Therapeutics Says Phase 2a Haduvio Trial Shows Significant Reduction in Cough Count
Mar 10, 2025
07:39 AM EDT, 03/10/2025 (MT Newswires) -- Trevi Therapeutics ( TRVI ) said Monday a phase 2a trial of its investigational drug Haduvio met the primary endpoint of a statistically significant reduction in 24-hour cough frequency in patients with refractory chronic cough. The company said Haduvio, or oral nalbuphine ER, achieved a reduction in 24-hour cough count of 67% from...
Rocket Signs Agreement to Acquire Redfin in $1.75 Billion All-Stock Transaction
Rocket Signs Agreement to Acquire Redfin in $1.75 Billion All-Stock Transaction
Mar 10, 2025
07:36 AM EDT, 03/10/2025 (MT Newswires) -- Rocket Companies ( RKT ) said Monday it has entered into an agreement to acquire Redfin (RDFN) in an all-stock transaction for $12.50 per share for an equity value of $1.75 billion. Under terms of the agreement, each share of Redfin common stock will be exchanged for a fixed ratio of 0.7926 shares...
Copyright 2023-2026 - www.financetom.com All Rights Reserved